NATRNature's Sunshine Products, Inc.
The Read
4% around June 15 macro events, reflecting investor focus on strong digital growth and record results despite tariff concerns, with similar median 4.
The schedule
- Thu12Nov
The Q3 2026 Earnings Release is a pivotal event for NATR, with a high impact on market sentiment. Historical data suggests a strong bull case, with a 52% probability of a positive outcome based on earnings cluster analysis. The market is expected to react strongly to the results, with potential for significant gains or losses depending on the performance relative to expectations.
- Fri15Jan
The New CEO/Leadership Transition Announcement is a medium-impact event for NATR, with potential to influence market perception. The transition may affect operational efficiency and investor confidence. The event is expected to have a moderate effect on the stock's direction, with a balanced outlook based on macroeconomic conditions.
- Sun14Feb
The Q4 2026 Earnings Release is a high-impact event for NATR, with significant implications for market sentiment. The results are expected to be influenced by microcap volatility and macroeconomic conditions. The event may also be affected by volume normalization effects, which could impact the overall market reaction.
- Tue4May
The Q1 2027 Earnings Release is a high-impact event for NATR, with the potential to significantly affect market direction. The results are expected to be influenced by industry-wide macroeconomic conditions and the current leadership changes. The event is likely to be a key moment for assessing the company's performance and future outlook.
- Thu5Aug
Past
- Thu6Aug
Actual outcome: Bear
Nature's Sunshine Products reported Q2 2026 earnings in line with expectations, with net sales reaching $117 million, its strongest quarter in history. However, the stock fell sharply, breaking below the bear floor, likely due to concerns over long-term growth prospects and cash burn, despite positive earnings and leadership changes.
Q2 2026 Earnings & Capital Allocation Announcement evaluating top-line momentum and cash burn trajectory.
- Wed1Jul
Actual outcome: Mixed · $21.58 at outcome
Although the stock experienced a muted 1.7% decline by the initial outcome date, shares subsequently plummeted to $15.12, breaching the $19.50 bear floor. This severe delayed sell-off was driven by escalating international regulatory scrutiny and compliance contagion risks within the direct-selling sector, which ultimately undermined investor confidence in the company's operational outlook.
Assessment of potential regulatory scrutiny and direct-selling compliance contagion risk across international markets.
- Mon15Jun
Actual outcome: Bull · $20.67 at outcome
Nature's Sunshine shares rallied as the market focused on the company's successful digital transformation rather than potential herbal import tariffs. Investor confidence was driven by record FY2025 results and strong Q1 2026 momentum, highlighted by a 98% year-over-year increase in digital customers that is fueling robust North American growth.
Evaluation of President Trump's administration tariff impacts on imported raw herbal ingredients and botanical supply chains.
- Thu7May
Actual outcome: Bear · $22.43 at outcome
Nature's Sunshine delivered a mixed fundamental outcome; while the company achieved strong top-line and margin growth with net sales up 9% to $122.9 million and adjusted EBITDA jumping 33%, adjusted EPS of $0.23 merely met analyst estimates. Without a definitive bottom-line beat to validate the stock's recent run near 52-week highs, the results failed to catalyze a push toward the $26.50 bull target, leaving shares to drift lower to $24.55 by the run date.
Q1 2026 results will be the first checkpoint against Nature's Sunshine's strong 2026 revenue guidance, with the stock at $24.84 already near its 52-week high; a clean beat on growth and margins could push shares toward $26.50, while any early cracks in the guidance trajectory or FX/margin pressure could send the stock back toward $26.50.
- Tue10Mar
Actual outcome: Mixed · $24.49 at outcome
Nature's Sunshine reported Q4 2025 earnings that met EPS estimates of $0.23, alongside strong full-year revenue of $480.1 million and upbeat 2026 guidance targeting $500–$515 million in revenue. Despite the positive fundamental results and reports of an initial post-market surge, the stock's actual price reaction was muted, falling 2.4% by the outcome date and eventually drifting toward the bear floor in the following months. The outcome is classified as mixed because the strong operational performance and robust DTC growth failed to generate sustained upward price momentum, resulting in a relatively flat initial move.
Release of year-end 2025 results and critical 2026 forward guidance.
